Investor mix
3 investors on record; lead investors include Samsara BioCapital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 100% |
Developer of trifunctional effector cell response inhibitors for allergic diseases
3 investors on record; lead investors include Samsara BioCapital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 100% |